Latest News on Clinical Trials

Kiniksa Highlights Phase 2 Study Data Showing the Corticosteroid-Sparing Effect of Rilonacept in Patients with Recurrent Pericarditis at the American College of Cardiology’s 69th Annual Scientific Session

- Phase 2 study data show the potential for rilonacept treatment to eliminate or reduce the risk of corticosteroid-associated morbidity in recurrent pericarditis - - Enrollment complete for the pivotal Phase 3 trial of rilonacept in recurrent pericarditis (RHAPSODY);...

read more

AML Trial Halted Due to COVID-19 Pandemic

A phase II trial of ficlatuzumab (AV-299), an investigational HGF inhibitory antibody, in patients with relapsed and refractory acute myeloid leukemia (AML) joins the growing list of clinical trials halted due to the coronavirus disease 2019 (COVID-19) pandemic....

read more

Biospace Clinical Trial Review for March 23 – 27

The COVID-19 pandemic continues to dominate the news and is likely to for quite some time. The biopharma industry is doing what it can to test and repurpose therapies, develop diagnostics and respond to the crisis. Also, although some clinical trials are being slowed...

read more